From: Becker's Spine Review <editorial@beckershealthcare.com>
Subject: 315 spine surgeons to know - 2016 | MedStar Washington patient death ruled homicide: 5 things to know | NuVasive acquires Ellipse Technologies for $380M: 7 key notes | 10 things to know about high deductible health plans
Preheader:
Reply: editorial@beckershealthcare.com
Tex View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+
   
Jan. 7, 2016
Top Articles
1. 315 spine surgeons to know - 2016 Full story
  
2. MedStar Washington patient death ruled homicide: 5 things to know Full story
 
3. Smith & Nephew acquires Blue Belt Technologies - Will Stryker make it's move soon? 5 key notes Full story
  
4. Webinar: What are the ins and outs of freight management? Click here
  
5. Mazor sells 25 robotic spine systems in Q4 - 5 key notes Full story
 
6. NuVasive acquires Ellipse Technologies for $380M: 7 key notes Full story
 
7. 131 physicians speaking, primary surgeons at Becker's 14th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference June 9-11 in Chicago. Click here to learn more and register.
  
  

8. 10 things to know about high deductible health plans Full story
 
9. Spine surgeon leader to know: Dr. Saeed Bajway of Southern New York Neurosurgical Group Full story  

10. Whitepaper: How to choose the right business entity. Download here
                    
 
     
Channels
_____________________
Contact Us

Editorial Contact: 
Laura Dyrda
Editor-in-chief
(800) 417-2035
email editorial

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's Spine Review
A Becker's Healthcare Publication
  www.BeckersSpine.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601




Copyright © 2014. All Rights Reserved.
Becker's Spine Review, 35 E. Wacker Dr. #1782, Chicago, IL 60601
SafeUnsubscribe™ scott@beckersasc.com
Forward this email | Update Profile | About our service provider
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact